BAC-PB(BAC-PB)
BAC-PB
Q4 2026 EPS Estimate
$1.19
Oct 14, 2026 · Reports before open
Revenue Estimate
$31.31B
FY2026E EPS$4.64
FY2027E EPS$5.26
Analyst Sentiment
Wall St. Consensus
Hold32 analysts·High coverage
60
Score
15 Buy (47%)15 Hold (47%)2 Sell (6%)
Rating Breakdown
Strong Buy
00%
Buy
1547%
Hold
1547%
Sell
26%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$40.00
+70.0%
Consensus
$40.00
+70.0%
Bull
$40.00
+70.0%
12-Month Target Range32 analysts
$40.00$40.00$40.00
Current $23.53Consensus
Current Price
$23.53
Upside to Consensus
$16.47
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.25%
EPS+13.36%
FY2028
Rev+4.58%
EPS+12.03%
FY2029
Rev-2.28%
EPS+15.69%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $124.02B | $130.53B | $136.51B | $133.40B |
| Low | $122.86B | $128.85B | $134.98B | $131.91B |
| High | $126.37B | $134.20B | $139.74B | $136.56B |
| EBITDA Avg | $41.45B | $46.36B | $51.47B | $59.12B |
| Low | $40.87B | $45.71B | $50.73B | $58.27B |
| High | $42.66B | $47.74B | $53.01B | $60.91B |
| EBIT Avg | $39.59B | $44.88B | $50.28B | $58.17B |
| Low | $39.02B | $44.23B | $49.55B | $57.33B |
| High | $40.81B | $46.26B | $51.83B | $59.96B |
| Net Income Avg | $35.65B | $40.42B | $45.28B | $52.38B |
| Low | $35.14B | $39.83B | $44.62B | $51.62B |
| High | $36.75B | $41.66B | $46.67B | $53.99B |
| EPS Avg | $4.64 | $5.26 | $5.89 | $6.82 |
| Low | $4.57 | $5.19 | $5.81 | $6.72 |
| High | $4.78 | $5.42 | $6.08 | $7.03 |
| Analysts (Rev / EPS) | 12 / 1 | 12 / 1 | 5 / 1 | 10 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $31.31B | $30.79B | $32.21B | $32.82B | $32.79B | $32.42B | $33.82B | $34.05B |
| Low | $30.82B | $30.20B | $31.65B | $32.25B | $32.21B | $31.85B | $33.23B | $33.45B |
| High | $32.11B | $31.43B | $32.96B | $33.58B | $33.55B | $33.17B | $34.61B | $34.84B |
| EBITDA Avg | $10.17B | $9.93B | $10.44B | $11.39B | $11.59B | $11.39B | $11.68B | $12.30B |
| Low | $9.95B | $9.71B | $10.21B | $11.15B | $11.34B | $11.14B | $11.42B | $12.03B |
| High | $10.46B | $10.21B | $10.74B | $11.72B | $11.93B | $11.72B | $12.02B | $12.66B |
| EBIT Avg | $9.62B | $9.41B | $9.94B | $10.93B | $11.15B | $10.97B | $11.28B | $11.92B |
| Low | $9.41B | $9.19B | $9.72B | $10.68B | $10.90B | $10.72B | $11.02B | $11.65B |
| High | $9.91B | $9.69B | $10.24B | $11.25B | $11.48B | $11.30B | $11.62B | $12.28B |
| Net Income Avg | $8.67B | $8.47B | $8.95B | $9.84B | $10.04B | $9.88B | $10.16B | $10.73B |
| Low | $8.47B | $8.28B | $8.75B | $9.61B | $9.81B | $9.65B | $9.92B | $10.49B |
| High | $8.93B | $8.73B | $9.22B | $10.13B | $10.34B | $10.17B | $10.46B | $11.06B |
| EPS Avg | $1.19 | $1.16 | $1.23 | $1.35 | $1.38 | $1.35 | $1.39 | $1.47 |
| Low | $1.16 | $1.13 | $1.20 | $1.32 | $1.35 | $1.32 | $1.36 | $1.44 |
| High | $1.22 | $1.20 | $1.26 | $1.39 | $1.42 | $1.39 | $1.43 | $1.52 |
| Analysts (Rev / EPS) | 9 / 1 | 9 / 1 | 7 / 1 | 4 / 1 | 4 / 1 | 7 / 1 | 7 / 1 | 3 / 1 |
